Firemans Contractors, Inc. (OTCBB: FRCN) (OTCQB: FRCN) reached up 20% in morning trading to $.0036 with 8M shares traded. Firemans Contractors, Inc. is a full-service contractor providing professional services for commercial and government clients, offering Business to Business Franchise Opportunities. Its services include Road Improvements, Pavement Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Firemans Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The company's goal is to develop hundreds of new franchise locations in the next 24 to 48 months. Firemans Contractors, Inc. (FRCN) announced today that the company benefited from a total combined repeat business of 36% and 61% in 2010 and 2011, respectively, with the stimulus seeming to stem from continuous additions of Fortune 500 companies and large property management companies to the client portfolio.
Punchline Entertainment Inc. (OTCQB: PUNL) (OTCBB: PUNL) reached up 9.28% in morning trading to $1.06 with 500K shares traded. Punchline Entertainment Inc. (soon to be Punchline Resources Ltd.) is an emerging mineral resources company focused on both domestic and international exploration and development projects. The Company is currently evaluating several projects for potential acquisition and/or participation. Punchline Entertainment Inc. (PUNL) announced Friday that the Company has initiated discussions to potentially acquire interests in one or more gold exploration and development projects. The projects currently being considered are located in both North America and internationally.
Zalicus Inc. (NASDAQ: ZLCS) reached up 9.52% in morning trading to $1.38 with 4M shares traded. Zalicus Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Zalicus has a portfolio of proprietary clinical-stage product candidates targeting pain and immuno-inflammatory diseases and have entered into multiple revenue-generating collaborations with large pharmaceutical companies relating to other products, product candidates and drug discovery technologies. Zalicus applies its expertise in the discovery and development of selective ion channel modulators and its combination high throughput screening capabilities to discover innovative therapeutics for itself and its collaborators in the areas of pain, inflammation, oncology and infectious disease. Zalicus Inc. (ZLCS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO® (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
